ScanSource Q2 sales and EPS miss analyst estimates

Reuters
02/05
<a href="https://laohu8.com/S/SCSC">ScanSource</a> <a href="https://laohu8.com/S/QTWO">Q2</a> sales and EPS miss analyst estimates

Overview

  • Technology distributor's Q2 FY26 sales missed analyst expectations

  • Adjusted EPS for Q2 FY26 missed analyst expectations

  • Company announced leadership changes in board committees

Outlook

  • ScanSource revises FY26 net sales forecast to $3.0 bln-$3.1 bln from $3.1 bln-$3.3 bln

  • Company lowers FY26 adjusted EBITDA forecast to $140 mln-$150 mln from $150 mln-$160 mln

  • ScanSource maintains FY26 free cash flow forecast at least $80 mln

Result Drivers

  • RECURRING REVENUE GROWTH - Recurring revenue increased 15.9% year-over-year, contributing significantly to overall sales growth

  • SEGMENT PERFORMANCE - Specialty Technology Solutions and Intelisys & Advisory segments drove sales growth, with North America leading the increase

  • CASH FLOW STRENGTH - Company reported strong free cash flow, supporting its strategic goals

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Sales

Miss

$766.51 mln

$779.40 mln (3 Analysts)

Q2 Adjusted EPS

Miss

$0.80

$1.01 (4 Analysts)

Q2 Adjusted Net Income

$17.61 mln

Q2 Adjusted EBITDA

$31.19 mln

Q2 Gross Profit

$102.91 mln

Q2 Operating Income

$17.87 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the computer hardware peer group is "buy"

  • Wall Street's median 12-month price target for Scansource Inc is $50.00, about 12.8% above its February 4 closing price of $44.33

  • The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 10 three months ago

Press Release: ID:nBw1psJ9Ka

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10